Suppr超能文献

与RPS19基因突变相关的波氏孔疝合并先天性纯红细胞再生障碍性贫血:一例报告

Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.

作者信息

Yoo Ye Seul, Lee Na Hee, Choi Young Bae

机构信息

Department of Pediatrics, Chungbuk National University Hospital, Cheongju.

Department of Pediatrics, Cha Bundang Medical Center, Cha University, Seongnam, Korea.

出版信息

Medicine (Baltimore). 2019 Sep;98(39):e17337. doi: 10.1097/MD.0000000000017337.

Abstract

RATIONALE

Diamond-Blackfan anemia (DBA) is a rare inherited marrow disorder, characterized by erythrocyte aplasia and is associated with congenital anomalies and a susceptibility to cancer. Although congenital abnormalities have been observed in ∼50% of DBA patients, the occurrence of an associated congenital diaphragmatic hernia (CDH) has rarely been reported.

PATIENT CONCERNS

A 19-month-old male child was referred to our pediatric hematology-oncology outpatient clinic with anemic appearance. He presented to us with recurrent anemia, short stature, and developmental delay.

DIAGNOSIS

On bone marrow examination, only erythropoietic cells were markedly decreased in number, whereas other cell lines were unaffected. An abdominal computed tomography scan revealed a Bochdalek type of CDH. A genetic analysis revealed heterozygous mutation of RPS19; therefore, he was diagnosed as having DBA with CDH.

INTERVENTIONS

The patient received an initial packed red blood cell transfusion, followed by an administration of oral prednisone.

OUTCOMES

The patient is maintained on oral prednisone administered at a dose of 0.3 mg/kg every alternate day and has since a hemoglobin level of >9.0 g/dL without further RBC transfusions.

LESSONS

We learned that a Bochdalek type of CDH can manifest in a DBA patient with RPS19 gene mutation. Therefore, patients diagnosed with the latter disorder should also be screened for an early detection of potential CDHs.

摘要

原理

先天性纯红细胞再生障碍性贫血(DBA)是一种罕见的遗传性骨髓疾病,其特征为红细胞发育不全,并与先天性畸形和癌症易感性相关。虽然在约50%的DBA患者中观察到先天性异常,但相关先天性膈疝(CDH)的发生却鲜有报道。

患者情况

一名19个月大的男童因面色贫血被转诊至我们的儿科血液肿瘤门诊。他表现为反复贫血、身材矮小和发育迟缓。

诊断

骨髓检查显示,只有造血红细胞数量明显减少,而其他细胞系未受影响。腹部计算机断层扫描显示为波氏孔型CDH。基因分析显示RPS19杂合突变;因此,他被诊断为患有DBA合并CDH。

干预措施

患者最初接受了浓缩红细胞输血,随后口服泼尼松。

结果

患者维持隔日口服0.3mg/kg剂量的泼尼松,此后血红蛋白水平>9.0g/dL,无需进一步输注红细胞。

经验教训

我们了解到波氏孔型CDH可在患有RPS19基因突变的DBA患者中表现出来。因此,被诊断为后者疾病的患者也应进行筛查,以便早期发现潜在的CDH。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/551b/6775407/7129ad00c0d0/medi-98-e17337-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验